07.02.2014 Views

ICT and e-Business in the Pulp, Paper and Paper ... - empirica

ICT and e-Business in the Pulp, Paper and Paper ... - empirica

ICT and e-Business in the Pulp, Paper and Paper ... - empirica

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

<strong>Pulp</strong>, paper <strong>and</strong> paper products<br />

Ano<strong>the</strong>r lesson is that <strong>the</strong> <strong>in</strong>itial excitement of smaller partners for papiNet® implementation<br />

is often dampened when <strong>the</strong> magnitude of <strong>the</strong> task relative to <strong>the</strong>ir exist<strong>in</strong>g<br />

implementation of ERP is understood. Even though papiNet® is universally recognised as<br />

be<strong>in</strong>g a very good st<strong>and</strong>ard, specific implementations <strong>in</strong> particular market sub-sectors do<br />

not require all of <strong>the</strong> data elements <strong>in</strong> <strong>the</strong> st<strong>and</strong>ard papiNet® messages. For example<br />

hav<strong>in</strong>g to process a full general papiNet® message would be perceived as an “overkill” by<br />

those whose "ERP system" may be an EXCEL spreadsheet. This is well understood <strong>and</strong><br />

is be<strong>in</strong>g addressed via <strong>the</strong> Segment Implementation Groups <strong>in</strong> papiNet.<br />

The PackAgent project was designed <strong>in</strong> anticipation of much tighter rules on record<strong>in</strong>g<br />

<strong>and</strong> track<strong>in</strong>g <strong>the</strong> pedigree of pharmaceuticals. These m<strong>and</strong>atory rules have s<strong>in</strong>ce been<br />

realised. The US Food <strong>and</strong> Drug Adm<strong>in</strong>istration announced <strong>the</strong> end of <strong>the</strong>ir hold on <strong>the</strong><br />

implementation date for e-pedigree legislation, orig<strong>in</strong>ally enacted as <strong>the</strong> Prescription Drug<br />

Market<strong>in</strong>g Act <strong>in</strong> 1998. Prior to <strong>the</strong> 1 st December 2006, it is expected that <strong>the</strong> FDA will<br />

issue a draft Compliance Policy Guide. From that date <strong>the</strong> FDA enforcement of <strong>the</strong><br />

pedigree regulations will focus on products considered most susceptible to counterfeit<strong>in</strong>g<br />

<strong>and</strong> diversion. At that time it must be possible for distributors to be able to track <strong>and</strong> trace<br />

specific drugs. Thus <strong>the</strong> expectations <strong>and</strong> statutory requirements for packag<strong>in</strong>g<br />

traceability based on technology such as RFID are now clear <strong>and</strong> RFID technology will be<br />

used widely throughout <strong>the</strong> pharmaceutical <strong>in</strong>dustry from 2007 onwards to improve<br />

security <strong>and</strong> safety concerns <strong>in</strong> <strong>the</strong> track<strong>in</strong>g of medical drugs.<br />

One lesson for policy consideration from <strong>the</strong> PackAgent Pilot is that <strong>the</strong> legal status <strong>and</strong><br />

any timetable for implementation of m<strong>and</strong>atory e-pedigree <strong>in</strong> Europe needs to be clearly<br />

established to enable packag<strong>in</strong>g companies <strong>and</strong> <strong>the</strong>ir partners to plan accord<strong>in</strong>gly. The<br />

requirement is fairly self-evident. Products ship across borders, <strong>and</strong> companies sell <strong>in</strong><br />

every country, <strong>the</strong>refore EU Member State national rules <strong>and</strong> requirements must be<br />

compatible. Significantly different practices between <strong>the</strong> Members States will render it<br />

very difficult to have a common approach across <strong>the</strong> European market.<br />

Conclusions<br />

The future of <strong>the</strong> packag<strong>in</strong>g <strong>in</strong>dustry is an excit<strong>in</strong>g one, especially if it can move from a<br />

commodity-oriented bus<strong>in</strong>ess to a packag<strong>in</strong>g system <strong>in</strong>dustry. The path is full of<br />

possibilities for imag<strong>in</strong>ative <strong>and</strong> creative <strong>ICT</strong> enabled products <strong>and</strong> services which meet<br />

<strong>the</strong> needs of <strong>the</strong> <strong>in</strong>dustry, <strong>the</strong> customers, <strong>the</strong>ir products <strong>and</strong> <strong>the</strong> regulators <strong>in</strong> ways we<br />

can hardly imag<strong>in</strong>e today.<br />

Kirsi Viskari’s vision, however, is clear: “PackAgent capabilities <strong>and</strong> design features<br />

<strong>in</strong>dicate <strong>the</strong> way. The fundamental prerequisite is to move beyond supply cha<strong>in</strong> efficiency<br />

to <strong>in</strong>tegrat<strong>in</strong>g supply <strong>and</strong> distributed management of <strong>in</strong>formation <strong>in</strong> products <strong>in</strong> l<strong>in</strong>e with<br />

dem<strong>and</strong> <strong>and</strong> <strong>in</strong>creas<strong>in</strong>g expectations. In addition to <strong>the</strong> <strong>in</strong>teroperability <strong>and</strong> associated<br />

st<strong>and</strong>ards challenges, above all else this requires <strong>the</strong> establishment <strong>and</strong> nurtur<strong>in</strong>g of<br />

alliances, research networks <strong>and</strong> commercial jo<strong>in</strong>t venture outside <strong>the</strong> traditional<br />

packag<strong>in</strong>g sector”.<br />

103

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!